Efficacy of the latest fluoroquinolones against experimental Yersinia pestis

Int J Antimicrob Agents. 2004 Dec;24(6):609-12. doi: 10.1016/j.ijantimicag.2004.06.011.

Abstract

The efficacies of prophylactic and therapeutic gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of systemic and pneumonic plague and compared with ciprofloxacin. Mice were given 100 mg/kg of the antibiotic by oral administration twice daily for 7 days starting 1h prior to infection or following infection. All antibiotics offered full protection for up to 6h following systemic challenge, and for up to 30 h following an aerosol challenge. The efficacy of each of the antibiotics decreased when antibiotics were started 18 h following systemic challenge and 48 h following aerosol challenge. Fluoroquinolones may therefore be considered useful candidates for the treatment of bubonic and pneumonic plague.

MeSH terms

  • Animals
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use
  • Disease Models, Animal
  • Fluoroquinolones / pharmacokinetics
  • Fluoroquinolones / pharmacology*
  • Fluoroquinolones / therapeutic use*
  • Gatifloxacin
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests
  • Plague / drug therapy*
  • Plague / microbiology
  • Plague / prevention & control
  • Yersinia pestis / drug effects*

Substances

  • Fluoroquinolones
  • Ciprofloxacin
  • Gatifloxacin